Selective inhibition of COX-2 is beneficial to mice infected intranasally with VSV

Nannan Chen1, Andrew Restivo, Carol Shoshkes Reiss

  • 1Department of Biology, New York University, NY 10003, USA.

Insights

Inhibition of cyclooxygenase-2 (COX-2) enhances the central nervous system's antiviral defense against Vesicular Stomatitis Virus (VSV) by boosting innate immunity. COX-1 inhibition did not show similar protective effects.

Area of Science:

  • Neuroimmunology
  • Virology
  • Enzymology

Background:

  • Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, are crucial for prostaglandin synthesis and are present in the central nervous system (CNS).
  • Their roles in CNS viral infections and host defense remain largely uncharacterized.
  • Prostaglandins mediate physiological and inflammatory responses within the brain.

Purpose of the Study:

  • To investigate the distinct roles of COX-1 and COX-2 in the host immune response to viral encephalitis in the CNS.
  • To determine the impact of inhibiting COX-2 on viral load and immune cell infiltration during Vesicular Stomatitis Virus (VSV) infection.

Main Methods:

  • Utilized a mouse model of Vesicular Stomatitis Virus (VSV)-induced acute encephalitis.
  • Administered a selective COX-2 inhibitor (celecoxib) and a COX-1 antagonist (SC560).
  • Assessed viral titers, immune cell recruitment (neutrophils), and expression of key immune mediators like 5-lipooxygenase (5-LO), Nitric Oxide Synthase-1 (NOS-1), IFN-gamma, and IL-12.

Main Results:

  • Inhibition of COX-2 with celecoxib significantly reduced viral titers in the CNS.
  • COX-1 antagonism did not yield similar reductions in viral load.
  • Celecoxib treatment led to increased expression of 5-LO, NOS-1, IFN-gamma, and IL-12, alongside enhanced neutrophil recruitment.

Conclusions:

  • COX-2 plays a detrimental role in the CNS antiviral immune response against VSV.
  • Selective COX-2 inhibition enhances innate immunity, promoting viral restriction through increased inflammatory mediators and immune cell infiltration.
  • Targeting COX-2 may represent a therapeutic strategy for CNS viral infections.

Related Concept Videos